Clinical trial
Acute Kidney Injury After Cardiac Surgery; A Prospective Randomized Study of Dextran Based and Crystalloid Priming Solutions (PRIMING II Trial)
NCT04293744 is registered in ClinicalTrials.gov with XVIVO Perfusion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Kidney Injury After Cardiac Surgery; A Prospective Randomized Study of Dextran Based and Crystalloid Priming Solutions (PRIMING II Trial)
- Lead sponsor
- XVIVO Perfusion
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- September 4, 2020
- Completion date
- October 31, 2023
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, cardiac surgical procedures, extracorporeal circulation; complications